Brian C. Stephenson - 16 Nov 2024 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role: Secretary, Treasurer & CFO
Signature: /s/ Brian C. Stephenson
Issuer symbol: BBIO
Transactions as of: 16 Nov 2024
Net transactions value: -$310,186
Form type: 4
Filing time: 19 Nov 2024, 18:06:20 UTC
Previous filing: 20 Aug 2024
Next filing: 20 Nov 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BBIO	Common Stock	Options Exercise		+25,799	+30%		110,991	16 Nov 2024	Direct	F1
transaction	BBIO	Common Stock	Tax liability	$310,186	-13,077	-12%	$23.72	97,914	16 Nov 2024	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BBIO	Restricted Stock Units	Options Exercise	$0	-778	-50%	$0.000000	779	16 Nov 2024	Common Stock	778		Direct	F1, F3
transaction	BBIO	Restricted Stock Units	Options Exercise	$0	-947	-20%	$0.000000	3,786	16 Nov 2024	Common Stock	947		Direct	F1, F4
transaction	BBIO	Restricted Stock Units	Options Exercise	$0	-17,369	-10%	$0.000000	156,315	16 Nov 2024	Common Stock	17,369		Direct	F1, F5
transaction	BBIO	Restricted Stock Units	Options Exercise	$0	-6,705	-7.1%	$0.000000	87,164	16 Nov 2024	Common Stock	6,705		Direct	F1, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F2	Represents the number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 25,799 shares of Common Stock underlying the Reporting Person's RSUs.
F3	The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2021. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
F4	The RSUs vested with respect to 25% of the underlying shares on November 16, 2022. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service to the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
F5	The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2023. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.
F6	The RSUs vested with respect to 1/16th of the underlying shares on May 16, 2024. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.